Schlieren, Switzerland

Delenex Therapeutics Ag


USPTO Granted Patents = 5



Forward Citations = 11

Loading Chart...
Loading Chart...

20 inventors (with patents filed for the assignee):

goldMedal Adrian Auf Der Maur (4 out of 17 patents)

silverMedal Roger Nitsch (2 out of 28 patents)

bronzeMedal Alcide Barberis (2 out of 22 patents)

4 Peter Lichtlen (2 out of 9 patents)

5 Stefan Ewert (2 out of 15 patents)

6 Susann Cattepoel (2 out of 2 patents)

7 Titus Kretzschmar (1 out of 9 patents)

8 Abdijapar Shamshiev (1 out of 9 patents)

9 Simone Schmitt (1 out of 6 patents)

10 Stefanie Grabulovski (1 out of 6 patents)

11 Thorsten Alexander Schäfer (1 out of 1 patent)

12 Annemarie Honegger (7 patents)

13 Simone Schmitt (1 patent)

14 Thorsten Alexander Schafer (0 patent)


5 patents:

Delenex Therapeutics Ag is a biopharmaceutical company dedicated to developing innovative antibody-based therapies for a wide range of diseases. With a focus on advancing precision medicine, Delenex is committed to discovering and delivering novel treatments that improve patient outcomes and quality of life. The company's cutting-edge research and development programs target areas such as oncology, immunology, and rare genetic disorders, with the goal of addressing unmet medical needs and transforming the future of healthcare.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

5 Patents

#15 in Schlieren

#1,658 in Switzerland

...
Schlieren, Switzerland
Forward Citations = 11

20 inventors:

Please report any incorrect information to support@idiyas.com
Loading…